PharmaCyte Biotech, Inc. (PMCB)

Company Overview
Nuvilex is an innovative company which aims at ionitiating a paradigm shift, generating revenue at the same time as creating cancer and other cell related solutions to treat important human diseases, such as pancreatic cancer while retaining our connections to natural products. The present effort underway will give rise to dramatic advances in cancer therapy and benefit millions of people worldwid
read more

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of May 29, 2015

Hotstocked Precision will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 04:24PM EDT May 29, 2015
$ 0.1587   -0 (-0.5%)
Today's Open: 0.158 Previous Close: 0.1595
Today's High: 0.1595 Volume: 1,536,413
Today's Low: 0.1552 Avg Vol: 1,668,961
52 Week High: 0.3348 Bid (size): 0
52 Week Low: 0.095 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: Meadows Corporate Park I, 12510 Prosperity Boulevard, Silver Spring, MD 20904, United States
Mailing Address: -
Phone: 240-696-6859
Fax: -
Website: http//www.nuvilex.com

Company Details:

Symbol: PMCB
SIC: -
State location: MD
Sector: -
State of Inc: NV
Employees: 1
Type: -

Key executives:

Name Age Position
2015
Dr. Gerald W. Crabtree 2015 COO
Patricia Gruden 2015 Chairman of the Board of Directors and CFO
Robert F. Ryan 2015 President, CEO

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of May 29, 2015

This free program will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB)'s Recovery Didn't Last May 8, 2015

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) had a nice little bounce on Wednesday, but yesterday's trading session nearly wiped all of its gains, in spite of the investors' relative inactivity. read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Catches a Break May 7, 2015

Yesterday PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) managed to log a sizable reversal session, after a predominantly red streak. The ticker shifted nearly 4.3 million shares and closed over 7% up, at $0.16 per share. read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Roller Coaster Continues April 22, 2015

The pullback that PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) is going through continued in yesterday's session. The stock slid over 10% on share volume that was dramatically faded compared to the previous sessions. PMCB stopped at $0.16 per share by the cl... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Steps on the Brakes April 20, 2015

After an impressive green run, on Friday the stock of PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) turned red once more. The price hike up the chart continued for a short while in the morning but PMCB ultimately stopped 6% down by the bell, at $0.204 per sha... read more

LATEST STOCK PROMOTIONS

PMCB announces appointment of former Pfizer exec to its board of... May 18, 2015, 19:07

  PharmaCyte Biotech, Inc. (PMCB)  PharmaCyte Biotech, Inc. (PMCB) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This unique and patented technology will be used as a platform upon which treatments for several types read more

Promoter: PST Alerts Paying Party: Galaxy LLC Max Profit: 0.46% Gain at close: Pending
Stock: pmcb Compensation: $5,000 Avg $ Volume for Period: UNKNOWN

PMCB announces appointment of former Pfizer exec to its board of... May 18, 2015, 19:06

PharmaCyte Biotech, Inc. (PMCB)  PharmaCyte Biotech, Inc. (PMCB) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. This unique and patented technology will be used as a platform upon which treatments for several types of cancer, read more

Promoter: Buzz Stocks Paying Party: Galaxy LLC Max Profit: 0.46% Gain at close: Pending
Stock: pmcb Compensation: $5,000 Avg $ Volume for Period: UNKNOWN

PennyStockProphet - PMCB - Biotech Pick Poised For Another Momentum... May 18, 2015, 18:11

  PSP Free Members, PMCB continues to be one of our Biggest Plays of 2015!  Do you remember what happened last time we made PMCB an official pick?  PMCB staged a massive rally just day’s after I alerted members to a key technical reversal pattern that was beginning to take shape. The result? PMCB Gained 109 Percent, with a High of 26.5 Cents, in less than 7 trading sessions! PMCB has performed read more

Promoter: Penny Stock Prophet Paying Party: Cream Consulting Max Profit: 0.46% Gain at close: Pending
Stock: pmcb Compensation: $15,000 Avg $ Volume for Period: UNKNOWN

Nuvilex, Inc. (NVLX) MESSAGE BOARD

Post # Subject Re Name Date
1 Such a deep anewsr! GD&RVVF 0
2 I love these areltics. How many words can... 0
3 Well, I think the Fed has to do a lot... 0
4 I just love how optimistic Jim Cramer and... 0
5 Dear Minamar,Can you give me some more... 0
6 Well mamiadcaa nuts, how about that. 0
7 I hope so 0
8 I'm a Dollarniare now! The scams on otc... 0
9 yes we are ging to be millionaires but it... 1
10 chemo kills weed does not 0
11 What happened to this stock today? It's... 0
12 Oh what happened? 2
13 Tanking like a ROCK!! Alpha Articles out!!! 4
14 FDA possible approval response to NVLX... 1
15 Yes it can 0
16 Man! I'd personally write some options... 0
17 20 Ducats? You jest my dear buffoon! 0
18 Oh Sheeheeheeheet! NVLX is fo' real ?... 0
19 50:1 split? Ha ha 0
20 with a 50:1 Reverse stock split! Yes... 0